Drug:
Reaction: URINARY TRACT INFECTION
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25138780 |
US |
65 | 1 |
COVID-19 pneumonia, Dehydration, Rhabdomyolysis, Heat stroke, Urinary tract infection, Productive cough, |
||||
ADALIMUMAB, |
||||
| 2 | 25139007 |
US |
58 | 2 |
Back injury, Road traffic accident, Stent placement, Cervical vertebral fracture, Ligament sprain, Uterine prolapse, COVID-19, Pneumonia, Urinary tract infection, Hand fracture, Intentional product use issue, Pulmonary mass, |
||||
IPRATROPIUM BROMIDE AND ALBUTEROL, IPRATROPIUM BROMIDE AND ALBUTEROL, ALBUTEROL SULFATE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MELATONIN, |
||||
| 3 | 25139277 |
US |
93 | 1 |
Urinary tract infection, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 4 | 25139550 |
CN |
||
Injection site reaction, Infection, Pneumonia, Urinary tract infection, |
||||
SATRALIZUMAB, |
||||
| 5 | 25139752 |
US |
2 | |
Urinary tract infection, Product use issue, |
||||
LEUPROLIDE ACETATE, |
||||
| 6 | 25140053 |
IL |
76 | 1 |
Localised infection, Urinary tract infection, Malaise, Pyrexia, |
||||
| 7 | 25140056 |
US |
2 | |
Loss of consciousness, Femur fracture, Urinary tract infection, Fall, |
||||
PANCRELIPASE, |
||||
| 8 | 25140057 |
US |
2 | |
Urinary tract infection, Pneumonia, |
||||
PANTOPRAZOLE SODIUM, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CYANOCOBALAMIN, CYANOCOBALAMIN, ALPRAZOLAM, LACOSAMIDE, MIRTAZAPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LINACLOTIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CLONAZEPAM, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, EVOLOCUMAB, CLOZAPINE, |
||||
| 9 | 25140518 |
JO |
||
Cytomegalovirus infection, Candida infection, Diarrhoea, Constipation, Abdominal pain, Gastritis viral, Gastroenteritis bacterial, Hypertension, Hypertensive encephalopathy, Chest pain, Urinary tract infection, Pyelonephritis, Respiratory tract infection, Sepsis, Otitis media acute, Gingivitis, Herpes zoster, Herpes simplex, Haemophilus infection, Varicella zoster virus infection, Fungal skin infection, Viral skin infection, Staphylococcal infection, Dermatitis allergic, Diabetes mellitus, Diabetic ketoacidosis, Hyperkalaemia, Hypokalaemia, Nephropathy toxic, Hydronephrosis, Anaemia, Thrombocytopenia, Leukopenia, Tremor, Psychotic disorder due to a general medical condition, Dehydration, Visual impairment, Oedema peripheral, Tooth abscess, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AZATHIOPRINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHYLPREDNISOLONE, |
||||
| 10 | 25140876 |
US |
1 | |
Urinary tract infection, Renal impairment, Infusion site erythema, Throat tightness, Blood uric acid increased, Flushing, |
||||
PEGLOTICASE, PEGLOTICASE, MYCOPHENOLIC ACID, MYCOPHENILIC ACID, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
| 11 | 25141009 |
CA |
68 | 1 |
Urinary tract infection, Intentional product use issue, Malaise, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 12 | 25141096 |
76 | 2 | |
Pneumonia, Urinary tract infection, |
||||
LENALIDOMIDE, |
||||
| 13 | 25141152 |
AU |
2 | |
Nephrolithiasis, Urinary tract infection, Brain fog, Dizziness, Drug ineffective, |
||||
GALCANEZUMAB-GNLM, ERENUMAB-AOOE, TOPIRAMATE, TOPIRAMATE SPINKLE, FREMANEZUMAB-VFRM, ONABOTULINUMTOXINA, PROPRANOLOL HYDROCHLORIDE, |
||||
| 14 | 25141347 |
US |
2 | |
Urinary tract infection, Hypotension, Heart rate irregular, |
||||
RIOCIGUAT, RIOCIGUAT, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), RIVAROXABAN, FLUOXETINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, MACITENTAN, OXYGEN, 0XYGEN, SIMVASTATIN, FUROSEMIDE, CYCLOSPORINE, |
||||
| 15 | 25142169 |
US |
22 | 2 |
Urinary tract infection, Ocular hyperaemia, Oral herpes, |
||||
DUPILUMAB, ERGOCALCIFEROL, |
||||
| 16 | 25142247 |
US |
25 | 2 |
Urinary tract infection, Illness, |
||||
TOFACITINIB, |
||||
| 17 | 25142446 |
CA |
60 | 2 |
Febrile neutropenia, Urinary tract infection, Staphylococcus test positive, |
||||
PEMBROLIZUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, DOXORUBICIN HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, OLANZAPINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, CARBOPLATIN, APREPITANT, FOSAPREPITANT DIMEGLUMINE, |
||||
| 18 | 25142560 |
US |
66 | |
Urinary tract infection, |
||||
RUXOLITINIB, |
||||
| 19 | 25142852 |
US |
1 | |
Urinary tract infection, Psychotic disorder, Product use issue, |
||||
| 20 | 25142881 |
NL |
2 | |
Pelvic fracture, Urinary tract infection, |
||||
| 21 | 25145097 |
93 | 2 | |
Urinary tract infection, |
||||
TOFACITINIB, |
||||
| 22 | 25145102 |
82 | 2 | |
Urinary tract infection, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 23 | 25145274 |
63 | 2 | |
Urinary tract infection, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 24 | 25138286 |
US |
30 | 2 |
Abdominal pain upper, Urinary tract infection, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 25 | 25138339 |
US |
76 | 2 |
Psoriatic arthropathy, Rheumatoid arthritis, Urinary tract infection, Chronic obstructive pulmonary disease, Night sweats, Abdominal pain upper, Drug ineffective, Gastrointestinal pain, |
||||
GUSELKUMAB, GUSELKUMAB, FLUCONAZOLE, |
||||
| 26 | 25138343 |
US |
2 | 2 |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 27 | 25138591 |
US |
2 | |
Condition aggravated, Fracture, Dyspnoea, Chest pain, Urinary tract infection, Cardiac disorder, Hip fracture, Upper limb fracture, Loss of personal independence in daily activities, Pain in extremity, Muscle spasms, Sternal fracture, Intentional dose omission, Fatigue, Constipation, Sleep disorder, Abdominal pain upper, Back pain, Product use in unapproved indication, Product dose omission in error, |
||||
ABALOPARATIDE, DILTIAZEM HYDROCHLORIDE, OXYCODONE, TORSEMIDE, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, SACUBITRIL AND VALSARTAN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PANCRELIPASE, |
||||
| 28 | 25137185 |
IE |
65 | 2 |
Lower respiratory tract infection, Pain in extremity, Urinary tract infection, |
||||
IBRUTINIB, ALLOPURINOL, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, FOLIC ACID, LEVOTHYROXINE, CALCIUM CARBONATE, ANTACID, |
||||
| 29 | 25137661 |
US |
2 | |
Urinary tract infection, Urinary tract infection, Vulvovaginitis staphylococcal, Unevaluable event, Unevaluable event, Irritable bowel syndrome, Escherichia infection, |
||||
ESTRADIOL, |
||||
| 30 | 25137687 |
PL |
||
Sudden death, Infection, Oedema peripheral, Circulatory collapse, Fatigue, Infection parasitic, Cardiac failure, Neoplasm malignant, Vomiting, Hyponatraemia, Thrombocytopenia, Arthralgia, Urinary tract infection, Diarrhoea, Constipation, Pyrexia, Chills, Neutropenia, Sinus node dysfunction, Febrile neutropenia, Arrhythmia, Tumour lysis syndrome, Nausea, Anaemia, Cardiac arrest, Decreased appetite, Epistaxis, Hyperphosphataemia, Arthralgia, Upper respiratory tract infection, Ischaemic stroke, Cough, Pneumonia, Cholestasis, Atrial fibrillation, Rash, |
||||
IBRUTINIB, VENETOCLAX, |
||||
| 31 | 25137698 |
US |
75 | 1 |
Urinary retention, Lethargy, Faeces soft, Hypotension, Urinary tract infection, Dizziness, Arthralgia, Asthenia, Hot flush, Abdominal pain, Back pain, Musculoskeletal stiffness, |
||||
FINASTERIDE, RELUGOLIX, RELUGOLIX, |
||||
| 32 | 25137829 |
DE |
71 | 2 |
COVID-19 pneumonia, Osteoporosis, Urinary tract infection, |
||||
LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ALLOPURINOL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FOLIC ACID, IPRATROPIUM BROMIDE, RAMIPRIL, |
||||
| 33 | 25137971 |
US |
||
Gastrointestinal disorder, Headache, Mood swings, Blood glucose fluctuation, Sleep disorder, Urinary tract infection, Cystitis, Kidney infection, Palpitations, Taste disorder, Decreased appetite, Eructation, Nausea, Vomiting, |
||||
TIRZEPATIDE, SEMAGLUTIDE, |
||||
| 34 | 25138077 |
IN |
1 | |
Type 2 diabetes mellitus, Escherichia sepsis, Acute kidney injury, Toxicity to various agents, Blood creatine decreased, Cough, Hypertension, Urinary tract infection, Off label use, |
||||
MYCOPHENOLIC ACID, MYCOPHENOLIC ACID, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 35 | 25140816 |
83 | 1 | |
Hypotension, Weight decreased, Sepsis, Pneumonia aspiration, Acute respiratory failure, Respiratory failure, Acute kidney injury, Urinary tract infection, Pseudomonas infection, Blood culture positive, Laboratory test interference, Staphylococcal infection, Skin disorder, Dysphagia, Malnutrition, Hypophagia, Dysarthria, Headache, Neck pain, Facial paralysis, Gait disturbance, Cerebrovascular accident, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, |
||||
| 36 | 25132053 |
US |
2 | |
Amniotic cavity infection, Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 37 | 25132066 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 38 | 25132071 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 39 | 25132073 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 40 | 25132077 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 41 | 25132078 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 42 | 25132083 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 43 | 25132086 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 44 | 25132089 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 45 | 25132090 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 46 | 25132100 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 47 | 25132317 |
US |
2 | |
Urinary tract infection, |
||||
MAVACAMTEN, |
||||
| 48 | 25133000 |
US |
1 | |
Respiratory distress, Seizure, Influenza, Urinary tract infection, Drug ineffective, |
||||
VIGABATRIN, VIGABATRIN, VIGABATRIN, LEVOTHYROXINE, PREDNISONE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 49 | 25133296 |
US |
2 | |
Urinary tract infection, |
||||
| 50 | 25133320 |
US |
||
Prostatitis, Urinary tract infection, |
||||
RELUGOLIX, RELUGOLIX, |
||||
| 51 | 25133526 |
CA |
53 | 2 |
Recurrent cancer, Metastatic neoplasm, Crohn^s disease, Urinary tract infection, Cough, Off label use, Therapeutic response decreased, Vertigo positional, Drug level below therapeutic, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 52 | 25133568 |
CN |
56 | |
Urinary tract infection, |
||||
DAPAGLIFLOZIN, |
||||
| 53 | 25133602 |
US |
50 | 2 |
Bladder discomfort, Nasal congestion, Urinary tract infection, Product use issue, |
||||
PLECANATIDE, |
||||
| 54 | 25133625 |
US |
2 | |
Amniotic cavity infection, Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 55 | 25134096 |
US |
63 | 1 |
Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 56 | 25134506 |
US |
2 | |
Condition aggravated, Hemiparesis, Pain, Chills, Depressed mood, Pyrexia, Dry throat, Dyspnoea, Malaise, Urinary tract infection, Central nervous system lesion, Insomnia, |
||||
OFATUMUMAB, |
||||
| 57 | 25134716 |
US |
2 | |
Amniotic cavity infection, Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 58 | 25135115 |
US |
20 | 2 |
Nephrotic syndrome, Urinary tract infection, Weight decreased, Exposure during pregnancy, Weight increased, Product dose omission issue, Product use issue, Hereditary angioedema, |
||||
WATER, STERILE WATER, STERILE WATER FOR INJECTION, EPINEPHRINE, ADRENALINUM, C1 ESTERASE INHIBITOR RECOMBINANT, |
||||
| 59 | 25135164 |
DE |
2 | |
Urinary tract infection, |
||||
| 60 | 25135190 |
AE |
85 | 1 |
Urinary tract infection, |
||||
| 61 | 25135588 |
US |
2 | |
Adrenal gland operation, Lethargy, Chapped lips, Drug effect less than expected, Lip exfoliation, Nightmare, Muscle spasms, Skin exfoliation, Lip dry, Constipation, Cortisol increased, Dehydration, Dyspepsia, Urinary tract infection, Headache, Nausea, Fatigue, Dry skin, Abdominal pain upper, Dizziness, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, SEMAGLUTIDE, INCLISIRAN, |
||||
| 62 | 25135605 |
GB |
1 | |
Sepsis, Bone cancer, Peripheral swelling, Blood potassium increased, Urinary tract infection, |
||||
PEMBROLIZUMAB, |
||||
| 63 | 25135617 |
US |
32 | 2 |
Pain, Myalgia, Urinary tract infection, |
||||
NATALIZUMAB, |
||||
| 64 | 25136013 |
AR |
6 | 1 |
Urinary tract infection, |
||||
SOMATROPIN, |
||||
| 65 | 25136093 |
US |
60 | 1 |
Depression, Initial insomnia, Hypertonia, Dehydration, Decreased appetite, Restlessness, Fatigue, Anxiety, Urinary tract infection, COVID-19, Muscle rigidity, Dry mouth, Speech disorder, Disturbance in attention, Hypotension, Agitation, Self-injurious ideation, Insomnia, Balance disorder, Negative thoughts, Fatigue, Asthenia, Inappropriate schedule of product administration, |
||||
DEUTETRABENAZINE, CLONAZEPAM, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, HYDROXYZINE, LINACLOTIDE, MONTELUKAST, MORPHINE SULFATE, OXYCODONE, PANTOPRAZOLE, PREGABALIN, TIZANIDINE, TOPIRAMATE, TOPIRAMATE SPINKLE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, QUETIAPINE, QUETIAPINE, |
||||
| 66 | 25136303 |
IT |
86 | 2 |
Urinary tract infection, Oedema peripheral, |
||||
LONCASTUXIMAB TESIRINE, |
||||
| 67 | 25136558 |
75 | 1 | |
Bacteriuria, Urinary tract infection, Pseudomonal bacteraemia, Epididymitis, |
||||
EMPAGLIFLOZIN, |
||||
| 68 | 25136898 |
CA |
55 | 2 |
Escherichia test positive, Febrile neutropenia, Urinary tract infection, |
||||
PEMBROLIZUMAB, BEVACIZUMAB, CARBOPLATIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SENNOSIDES, SENNA LEAF, SENNA, CISPLATIN, CLONAZEPAM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LEVOTHYROXINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, |
||||
| 69 | 25137044 |
US |
62 | 2 |
Sepsis, Back injury, Urinary tract infection, Cellulitis, Decreased immune responsiveness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 70 | 25137106 |
US |
77 | 2 |
Wrist fracture, Urinary tract infection, Drug ineffective, Abdominal pain upper, Unevaluable event, |
||||
RISANKIZUMAB-RZAA, |
||||
| 71 | 25140579 |
72 | 2 | |
Urinary tract infection, Oropharyngeal discomfort, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, |
||||
| 72 | 25126366 |
PT |
65 | 2 |
Respiratory tract infection, Somnolence, Urinary tract infection, Pyrexia, |
||||
AMANTADINE HYDROCHLORIDE, EZETIMIBE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, FUROSEMIDE, OPICAPONE, RAMIPRIL, MEMANTINE, MEMANTINE HYDROCHLORIDE, CARBIDOPA AND LEVODOPA, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, RIVASTIGMINE, RIVAROXABAN, |
||||
| 73 | 25126508 |
CA |
2 | |
Urinary tract infection, Dyspnoea, Emotional distress, Immunosuppression, Ophthalmic herpes zoster, Pulmonary mass, Mitral valve incompetence, Fatigue, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, AZATHIOPRINE, EFGARTIGIMOD ALFA, PREDNISONE, CALCIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DEXLANSOPRAZOLE, ALENDRONATE SODIUM, HYDROXYUREA, MAGNESIUM OXIDE, PYRIDOSTIGMINE BROMIDE, METOPROLOL TARTRATE, METOPROLOL, SULFASALAZINE, PYRIDOSTIGMINE BROMIDE, EFGARTIGIMOD ALFA, |
||||
| 74 | 25126548 |
US |
2 | |
Urinary tract infection, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, VITAMIN C, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, VITAMIN E, OXYGEN, 0XYGEN, NINTEDANIB, BENZONATATE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, MAGNESIUM, |
||||
| 75 | 25126597 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 76 | 25126612 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 77 | 25126619 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 78 | 25126629 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 79 | 25126633 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 80 | 25126676 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 81 | 25126682 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 82 | 25126687 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 83 | 25126690 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 84 | 25126700 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 85 | 25126898 |
US |
2 | |
Urinary tract infection, Injection site discolouration, Injection site erythema, Injection site pruritus, Injection site swelling, Skin mass, Injection site bruising, Rash pruritic, |
||||
BIMEKIZUMAB, FUROSEMIDE, CYANOCOBALAMIN, BUPROPION, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, |
||||
| 86 | 25127168 |
TN |
||
Sepsis, Endocarditis, Skin infection, Respiratory tract infection, Urinary tract infection, Ear, nose and throat infection, Off label use, Infection, |
||||
INFLIXIMAB, ADALIMUMAB-AACF, ADALIMUMAB, ETANERCEPT, TOCILIZUMAB, RITUXIMAB, |
||||
| 87 | 25127429 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 88 | 25127434 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 89 | 25127454 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 90 | 25127506 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 91 | 25127550 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 92 | 25127560 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 93 | 25127568 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 94 | 25127581 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 95 | 25127639 |
US |
38 | 1 |
Urinary retention, Urinary tract infection, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 96 | 25127658 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 97 | 25127676 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 98 | 25127699 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 99 | 25127701 |
CO |
1 | |
Urinary tract infection, |
||||
PALIVIZUMAB, |
||||
| 100 | 25127704 |
US |
2 | |
Urinary tract infection, Maternal exposure during pregnancy, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28